PD-1 expression on tumor cells: a new target for cancer therapy

被引：0
|
作者：
Tone, Mari [1 ,2 ]
Iwahori, Kota [1 ,2 ,3 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Clin Res Tumor Immunol, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Dept Clin Res Tumor Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2024年 / 13卷 / 01期
关键词：
Anti programmed death-1 antibody (anti-PD-1 antibody); cancer stemness; non-small cell lung cancer (NSCLC); chemoresistance; PATHWAYS;
D O I：
10.21037/tlcr-23-683
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：186 / 189
页数：4
相关论文
共 50 条
  • [31] MALAT 1 a modulator of PD-1/PD-L1 regulation in oral malignancies: An emerging target in cancer therapy
    Jayaraman, Selvaraj
    Sekar, Ramya
    Veeraraghavan, Vishnu Priya
    Raj, A. Thirumal
    Patil, Shankargouda
    ORAL ONCOLOGY, 2022, 130
  • [32] Testing PD-1/PD-L1 Expression in Cancer Therapy: Pathologic Insights and Economic Sustainability
    Montironi, Rodolfo
    Santoni, Matteo
    Tartari, Francesca
    Lopez-Beltran, Antonio
    Cheng, Liang
    Berardi, Rossana
    Scarpelli, Marina
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (06) : 501 - 502
  • [33] PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
    Simon, Sylvain
    Labarriere, Nathalie
    ONCOIMMUNOLOGY, 2018, 7 (01):
  • [34] Blockade of tumor expression of PD-1 promotes lung cancer growth in a murine model
    Du, Shisuo
    Guan, Qing
    Dicker, Adam P.
    Lu, Bo
    CANCER RESEARCH, 2017, 77
  • [35] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Huang, Haozhe
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
  • [36] Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer
    Dumitru, Adrian
    Dobrica, Elena-Codruta
    Croitoru, Adina
    Cretoiu, Sanda Maria
    Gaspar, Bogdan Severus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [37] Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy
    Wang, Yusha
    Zhang, Lei
    Bai, Yun
    Wang, Li
    Ma, Xuelei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
    Li, Yaqi
    Liang, Lei
    Dai, Weixing
    Cai, Guoxiang
    Xu, Ye
    Li, Xinxiang
    Li, Qingguo
    Cai, Sanjun
    MOLECULAR CANCER, 2016, 15
  • [39] Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
    Yaqi Li
    Lei Liang
    Weixing Dai
    Guoxiang Cai
    Ye Xu
    Xinxiang Li
    Qingguo Li
    Sanjun Cai
    Molecular Cancer, 15
  • [40] Prognostic impact of PD-L1 and PD-1 expression by primary tumor location in colorectal cancer.
    Berntsson, Jonna
    Larsson, Anna
    Nodin, Bjorn
    Eberhard, Jakob
    Jirstrom, Karin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345